David P. Southwell, Director: PTC Therapeutics PTCT Sell · Filed 23/04/19

Trade details

Type: Insider sale
Amount: $316,356.29
Shares · price: 6,241 sh · $50.69 a share
Held after: 15,688 sh
Stock: PTC Therapeutics PTCT
Person: David P. SouthwellDirector
Trade date: 23/04/17
Filed: 23/04/19
Days to filing: 2 days

Sold 28.5% of holdings

Share of holding sold: 28.5%

PTC Therapeutics trades, last 26 weeks

What else happened in PTC Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/18~23/05/17

David P. Southwell's recent trades

David P. SouthwellDirector
SellPTC Therapeutics
Sell
PTC Therapeutics
PTCT
$700.1K
12,000 sh
$700.1K
Filed 25/09/11
Traded 25/09/09
David P. SouthwellDirector
Planned salePTC Therapeutics
Planned sale
PTC Therapeutics
PTCT
$700.1K
12,000 sh
$700.1K
Filed 25/09/09
Traded 25/09/09
David P. SouthwellDirector
SellRocket Pharmaceuticals
Sell
Rocket Pharmaceuticals
RCKT
$1.4M
59,716 sh
$1.4M
Filed 24/04/16
Traded 24/04/12
David P. SouthwellDirector
SellRocket Pharmaceuticals
Sell
Rocket Pharmaceuticals
RCKT
$258.7K
10,284 sh
$258.7K
Filed 24/04/16
Traded 24/04/12
David P. SouthwellDirector
SellRocket Pharmaceuticals
Sell
Rocket Pharmaceuticals
RCKT
$240.5K
10,000 sh
$240.5K
Filed 24/04/16
Traded 24/04/15

David P. Southwell, Director — sold $316.4K of PTC Therapeutics PTCT · 28.5% of holdings · 10b5-1 plan | Whalegun